Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Balance Sheets

v3.22.1
Condensed Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current Assets    
Cash and Cash Equivalents $ 555,967 $ 148,284
Marketable Securities 11,003,071
Prepaid expenses 1,106,347 1,218
Total Current Assets 12,665,385 149,502
Non-Current Assets    
Operating Lease Right-of-Use Asset 149,009 527,195
Goodwill 10,498,539
Investment in Oravax, Inc. 1,500,000
Total Non-Current Assets 12,147,548 527,195
Total Assets 24,812,933 676,697
Current Liabilities    
Trade and Other Payables 986,626 1,104,801
Trade and Other Payables, related party 696,926
Operating Lease Liability 53,240 475,816
PPP Loan Payable 70,600
Total Current Liabilities 1,039,866 2,348,143
Non-Current Liabilities    
Due to MyMD Florida Shareholders 29,982
Line of Credit Payable– Related Party, net of discount 2,333,984
Notes Payable 1,200,000
Operating Lease Liability, net of current portion 95,911 51,602
Total Non-Current Liabilities 125,893 3,585,586
Total Liabilities 1,165,759 5,933,729
SHAREHOLDERS’ EQUITY/(DEFICIT)    
Additional Paid in Capital 43,411,487
Accumulated Deficit (78,561,568) (48,672,523)
Total Shareholders’ Equity/(Deficit) 23,647,174 (5,257,032)
Total Liabilities and Shareholders’ Equity/(Deficit) 24,812,933 676,697
Series C Convertible Preferred Stock [Member]    
SHAREHOLDERS’ EQUITY/(DEFICIT)    
Preferred stock, value
Series D Convertible Preferred Stock [Member]    
SHAREHOLDERS’ EQUITY/(DEFICIT)    
Preferred stock, value 144,524
Series E Junior Participating Preferred Stock [Member]    
SHAREHOLDERS’ EQUITY/(DEFICIT)    
Preferred stock, value
Common stock No Par Value [Member]    
SHAREHOLDERS’ EQUITY/(DEFICIT)    
Common stock 102,064,218
Common Stock Par Value [Member]    
SHAREHOLDERS’ EQUITY/(DEFICIT)    
Common stock $ 4,004